-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
StockNews.com Initiates Coverage on Jaguar Health (NASDAQ:JAGX)
StockNews.com Initiates Coverage on Jaguar Health (NASDAQ:JAGX)
StockNews.com started coverage on shares of Jaguar Health (NASDAQ:JAGX – Get Rating) in a report released on Monday. The brokerage set a "hold" rating on the biotechnology company's stock.
Jaguar Health Stock Down 2.9 %
Shares of JAGX stock opened at $0.16 on Monday. The stock has a market cap of $18.73 million, a P/E ratio of -0.14 and a beta of 1.65. Jaguar Health has a one year low of $0.15 and a one year high of $2.66. The stock has a fifty day moving average price of $0.24 and a 200 day moving average price of $0.36. The company has a debt-to-equity ratio of 8.47, a current ratio of 1.02 and a quick ratio of 0.73.
Get Jaguar Health alerts:Jaguar Health (NASDAQ:JAGX – Get Rating) last issued its earnings results on Monday, August 22nd. The biotechnology company reported ($0.12) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.10. The firm had revenue of $2.92 million during the quarter. Jaguar Health had a negative return on equity of 486.62% and a negative net margin of 652.35%. Analysts predict that Jaguar Health will post -0.67 earnings per share for the current year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Citigroup Inc. bought a new position in shares of Jaguar Health during the first quarter valued at $34,000. Goldman Sachs Group Inc. lifted its holdings in shares of Jaguar Health by 153.3% during the first quarter. Goldman Sachs Group Inc. now owns 54,770 shares of the biotechnology company's stock valued at $39,000 after acquiring an additional 33,148 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Jaguar Health by 507.3% during the first quarter. Bank of New York Mellon Corp now owns 169,749 shares of the biotechnology company's stock valued at $120,000 after acquiring an additional 141,796 shares during the period. Millennium Management LLC lifted its holdings in shares of Jaguar Health by 152.3% during the second quarter. Millennium Management LLC now owns 533,153 shares of the biotechnology company's stock valued at $157,000 after acquiring an additional 321,795 shares during the period. Finally, Virtu Financial LLC lifted its holdings in shares of Jaguar Health by 76.1% during the first quarter. Virtu Financial LLC now owns 229,270 shares of the biotechnology company's stock valued at $162,000 after acquiring an additional 99,073 shares during the period. 7.40% of the stock is owned by institutional investors.About Jaguar Health
(Get Rating)
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Recommended Stories
- Get a free copy of the StockNews.com research report on Jaguar Health (JAGX)
- Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
- Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
- Magna International is Your Auto and EV One-Stop Shop Stock
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com started coverage on shares of Jaguar Health (NASDAQ:JAGX – Get Rating) in a report released on Monday. The brokerage set a "hold" rating on the biotechnology company's stock.
斯托克新聞網在週一發佈的一份報告中開始對捷豹健康(納斯達克：JAGX-GET評級)的股票進行報道。該經紀公司對這家生物技術公司的股票設定了“持有”評級。
Jaguar Health Stock Down 2.9 %
捷豹健康類股下跌2.9%
Shares of JAGX stock opened at $0.16 on Monday. The stock has a market cap of $18.73 million, a P/E ratio of -0.14 and a beta of 1.65. Jaguar Health has a one year low of $0.15 and a one year high of $2.66. The stock has a fifty day moving average price of $0.24 and a 200 day moving average price of $0.36. The company has a debt-to-equity ratio of 8.47, a current ratio of 1.02 and a quick ratio of 0.73.
JAGX股票週一開盤報0.16美元。該股市值為1873萬美元，市盈率為-0.14，貝塔係數為1.65。捷豹健康的一年低點為0.15美元，一年高位為2.66美元。該股的50日移動均價為0.24美元，200日移動均價為0.36美元。該公司的債務權益比為8.47，流動比率為1.02，速動比率為0.73。
Jaguar Health (NASDAQ:JAGX – Get Rating) last issued its earnings results on Monday, August 22nd. The biotechnology company reported ($0.12) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.10. The firm had revenue of $2.92 million during the quarter. Jaguar Health had a negative return on equity of 486.62% and a negative net margin of 652.35%. Analysts predict that Jaguar Health will post -0.67 earnings per share for the current year.
捷豹健康(納斯達克代碼：JAGX-GET Rating)最近一次發佈財報是在8月22日星期一。這家生物技術公司公佈了本季度每股收益(0.12美元)，比普遍預期的(0.22美元)高出0.10美元。該公司本季度的收入為292萬美元。捷豹健康的淨資產回報率為負486.62%，淨利潤率為負652.35%。分析人士預測，捷豹健康今年的每股收益將為0.67美元。
Institutional Inflows and Outflows
機構資金流入和流出
About Jaguar Health
關於捷豹健康
(Get Rating)
(獲取評級)
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
捷豹健康公司是一家商業階段的製藥公司，專注於為患有胃腸道不適的人和動物開發處方藥，特別是慢性和衰弱的腹瀉。該公司通過兩個部門運營，人類健康和動物健康。它銷售Mytesi，用於對患有艾滋病毒/艾滋病的成年人進行抗逆轉錄病毒治療的非感染性腹瀉的症狀緩解。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Jaguar Health (JAGX)
- Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
- Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
- Magna International is Your Auto and EV One-Stop Shop Stock
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- 免費獲取StockNews.com關於捷豹健康的研究報告(JAGX)
- 阿徹·丹尼爾斯·米德蘭：49年增長的紅利英雄
- 全自動拖拉機會讓迪爾成為農業領域的特斯拉嗎？
- 麥格納國際是您的汽車和電動汽車一站式庫存
- 電動汽車電池製造商Freyr將在全球大舉擴張
- MarketBeat：回顧一週9/26-9/30
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受捷豹健康日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對捷豹健康和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧